Fluticasone Propionate Chemical Structure (Floventhfa Spl Graphic 01)
Flovent
Product Images NDC 50090-0910
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Flovent (NDC 50090-0910). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 1) (Floventhfa Spl Graphic 02)
Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Floventhfa Spl Graphic 03)
This text provides information about a study evaluating the change in FEV (Forced Expiratory Volume) from baseline. It mentions different treatments, including a placebo and various doses of FLOVENT HFA. Unfortunately, there is not enough information to determine the specific findings or conclusions of the study.*
Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Floventhfa Spl Graphic 04)
This text appears to show a chart or table with percentage values indicating the subjects' response to different doses of a medication. The chart includes different dosage levels and the corresponding percentage of subjects exhibiting a reduction in dose. The medication being evaluated is likely called "FLOVENT HFA" and comes in two different strengths: 440 mcg and 880 mcg, to be taken twice daily. Unfortunately, without further context or interpretation of the chart, it is challenging to provide a more specific description of what these percentages represent.*
Figure A (Floventhfa Spl Graphic 05)
Figure B (Floventhfa Spl Graphic 06)
Fgure C (Floventhfa Spl Graphic 07)
Figure D (Floventhfa Spl Graphic 08)
Figure E (Floventhfa Spl Graphic 09)
Figure F (Floventhfa Spl Graphic 10)
Figure G (Floventhfa Spl Graphic 11)
Figure H (Floventhfa Spl Graphic 12)
Figure I (Floventhfa Spl Graphic 13)
Floventhfa Spl Graphic 14
Label Image (Lbl500900910)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
